Breast cryoablation is a minimally invasive technique that destroys tumors by applying extreme cold, without the need for open surgery. As part of the series “Beyond the tumor: answering questions about ovarian and breast cancer,” Dr. José María Oliver, radiologist at the IVOQA Breast Unit, explains what this procedure involves and its benefits for breast cancer patients. This innovative treatment is one of the new therapeutic options in breast oncology for selected cases.
This content is part of a series organized by IVOQA and AMOH to provide practical, up-to-date, and empathetic information for patients and families, within the framework of a patient-centered approach based on personalized medicine.
What is breast cryoablation?
Cryoablation is an image-guided procedure that uses extremely low temperatures to destroy tumor tissue. It is performed by inserting a thin probe into the tumor, through which gas is released to freeze the cancerous tissue, forming an “ice ball” that induces cell necrosis. This method is included in the group of percutaneous ablation techniques, which have been widely studied in cancer treatment.
Clinical indications
This technique is mainly indicated in:
- Small, localized breast tumors.
- Patients with contraindications for conventional surgery.
- Selected cases of early-stage breast cancer.
- Patients who wish to avoid open surgery for medical or personal reasons.
Its use is spreading in contexts where breast conservation and minimal invasiveness are prioritized, with promising results in terms of oncological efficacy and patient satisfaction.
Clinical benefits
- Outpatient procedure, no need for prolonged hospitalization.
- Less aesthetic and emotional impact.
- Faster recovery compared to traditional surgery.
- Significant reduction in adverse effects associated with more aggressive treatments.
In addition, cryoablation preserves the breast anatomy without significant scarring, improving quality of life in cancer patients, especially young women or those with high body sensitivity.
Innovation in the treatment of breast cancer
Cryoablation is an effective and safe therapeutic alternative, especially in patients with comorbidities or advanced age. It is backed by clinical studies that support its efficacy in the local control of selected tumors. Its incorporation into specialized centers such as IVOQA reflects a commitment to innovation and personalized cancer treatment. This advance is part of precision oncology, which seeks to tailor each treatment to the needs and characteristics of each patient.
Education and support
This content is part of a series of conferences organized by IVOQA and AMOH Association, whose objective is to provide clear, up-to-date, and scientifically based information for patients and their families. The series addresses medical, emotional, and quality of life issues related to breast and ovarian cancer. Continuing education and emotional support are fundamental pillars of the comprehensive care model promoted by IVOQA.
